Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

PURPOSE: S-1 is a standard postoperative adjuvant chemotherapy for patients with stage II or III gastric cancer in Asia. Neoadjuvant or perioperative strategies dominate in Western countries, and docetaxel has recently shown significant survival benefits when combined with other standard regimens in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Yoshida, Kazuhiro, Kodera, Yasuhiro, Kochi, Mitsugu, Ichikawa, Wataru, Kakeji, Yoshihiro, Sano, Takeshi, Nagao, Narutoshi, Takahashi, Masazumi, Takagane, Akinori, Watanabe, Takuya, Kaji, Masahide, Okitsu, Hiroshi, Nomura, Takashi, Matsui, Takanori, Yoshikawa, Takaki, Matsuyama, Jin, Yamada, Makoto, Ito, Seiji, Takeuchi, Masahiro, Fujii, Masashi
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524985/
https://ncbi.nlm.nih.gov/pubmed/30925125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados